Form 4: Establishment Labs Director Gillin Acquires Shares in Lieu of Cash Retainer

Sentiment:

SEC Form 4 Filing


Director Leslie Gillin acquired 366 common shares of Establishment Labs Holdings Inc. in lieu of a quarterly cash retainer payment on December 31, 2024.

Summary

  • Leslie Gillin, a director of Establishment Labs Holdings Inc., acquired 366 common shares on December 31, 2024.
  • The shares were received in lieu of a quarterly cash retainer payment.
  • The acquisition price was $46.07 per share.
  • Following the transaction, Gillin directly owns 10,884 common shares.
  • The shares were issued under the company's 2018 Equity Incentive Plan.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine transaction related to director compensation. The director taking shares instead of cash is a mildly positive signal.

Positives

  • The director's decision to take shares instead of cash may signal confidence in the company's future performance.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. This transaction reflects a director's continued investment in the company.

Related Party Transactions

  • The transaction is a related party transaction as it involves a director receiving shares as part of their compensation.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it signals confidence from a director.

Key Dates

DateDescription
12/31/2024Date of transaction: Leslie Gillin acquired 366 common shares.
01/03/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.